Daily Stocks List: Falconstor Software Inc., ViaSat Inc. (NASDAQ:VSAT), Spartan Motors Inc. (NASDAQ:SPAR), Heat Biologics (NASDAQ:HTBX), AAC Holdings (NYSE:AAC)


Falconstor Software Inc. (NASDAQ:FALC) shares advanced 1.64% in last trading session and ended the day at $1.86. FALC Gross Margin is 80.00% and its has a return on assets of -9.90%. Falconstor Software Inc. (NASDAQ:FALC) quarterly performance is -8.37%.

On 26 January FalconStor Software® Inc. (NASDAQ:FALC), announced that Argentina-based managed service provider Imptech has selected the FreeStor® platform as a way to extend the value of its portfolio of offerings provided to customers in three key vertical markets.

ViaSat Inc. (NASDAQ:VSAT) ended the last trading day at $62.50. Company weekly volatility is calculated as 3.49% and price to cash ratio as 65.18. ViaSat Inc. (NASDAQ:VSAT) showed a weekly performance of 4.27%.

On 26 January, ViaSat Inc. (NASDAQ:VSAT), introduced new Exede® Business internet service plans that will offer a variety of affordable high-speed satellite internet service options for primary connectivity, plus a new internet back-up plan. The continuity service offers businesses a diverse access redundant connection to avoid service interruptions during outages with their primary internet service provider.

On 29 January, Spartan Motors Inc. (NASDAQ:SPAR) shares advanced 4.32% and was closed at $2.90. SPAR EPS growth in last 5 year was -40.40%. Spartan Motors Inc. (NASDAQ:SPAR) year to date (YTD) performance is -6.75%.

Spartan Motors, Inc. (NASDAQ:SPAR) will announce its fourth quarter and full year 2015 results prior to the market opening on Thursday, February 25, 2016. The Company will also host a webcast of its conference call on the same day at 10 a.m.

Heat Biologics, Inc. (NASDAQ:HTBX) shares decreased -8.24% in last trading session and ended the day at $2.45. HTBX has a return on assets of -91.10%. Heat Biologics, Inc. (NASDAQ:HTBX) quarterly performance is -40.24%.

Heat Biologics, Inc. (NASDAQ:HTBX), announced that Taylor Schreiber, M.D. Ph.D., Heat’s Chief Scientific Officer, discuss three-month interim data from the unblinded, monotherapy cohort of the company’s ongoing Phase 2 trial of HS-410 (vesigenurtacel-L) for the treatment of high risk, non-muscle invasive bladder cancer (NMIBC) at the Phacilitate Immunotherapy World Conference in Washington, D.C. on January 25-27, 2016.

AAC Holdings, Inc. (NYSE:AAC) caters to the Healthcare space. It has a net profit margin of 6.80% and weekly performance is 7.01%. On the last day of trading company shares ended up at $17.86. AAC Holdings, Inc. (NYSE:AAC) distance from 50-day simple moving average (SMA50) is -12.97%.

AAC Holdings, Inc. (NYSE:AAC) will issue its fourth quarter 2015 earnings release prior to the market opening on February 23, 2016 and host a conference call and live audio webcast, both open for the general public to hear, later that same day at 11:00 a.m. ET.


Leave a Reply

Your email address will not be published. Required fields are marked *